Health Care

Cape Fear Valley Ear, Nose & Throat completes first Inspire therapy procedure

By Staff Report, posted 1 year ago
 From left to right: Nurse Deandra Jacobs, Surgical Technologist Jayla Malloy, Dr. Jennifer Tartaglia and Surgical Technologist III Cynthia Mcintrye stand outside an operating room after the first Inspire procedure was completed March 12.
Photo provided by: CFVH 

Jennifer Tartaglia, M.D., of Cape Fear Valley Ear, Nose & Throat has completed the first Inspire procedure at Cape Fear Valley Ear, Nose & Throat. Inspire is an FDA-approved obstructive sleep apnea (OSA) treatment option for people who cannot use Continuous Positive Airway Pressure (CPAP) therapy.

OSA affects 22 million Americans. When left untreated, OSA can cause vehicle and workplace accidents, worsening mood and memory, stroke, heart attack and even death. It occurs when the airway collapses during sleep and blocks the flow of oxygen to the brain. The brain senses a lack of oxygen and wakes the body up just long enough to take a breath, then falls back asleep. This cycle repeats throughout the night and causes poor, disruptive sleep.

Inspire works inside the body with a patient’s natural breathing process to treat sleep apnea. Mild stimulation opens the airway during sleep, allowing oxygen to flow naturally. The patient uses a small handheld remote to turn Inspire on before bed and off when they wake up.

The Inspire system is implanted during a short, outpatient procedure. The system is placed under the skin of the neck and chest through two small incisions. Most patients return home the same day and take over-the-counter pain medications to manage pain as needed.

The safety and efficacy of Inspire was evaluated during the STAR clinical trial. Five-year STAR trial outcomes show patients using Inspire experience significant reductions in sleep apnea events and significant improvements in quality-of-life measures. There have been over 150 peer-reviewed publications on Inspire. These publications show results consistent with those seen in the STAR trial.

“We are excited to have completed the first Inspire procedure at CENTER,” said Dr. Tartaglia in a press release. “Inspire represents a significant advancement in treating sleep apnea. It is clinically proven to reduce sleep apnea events, has a high level of patient satisfaction and a high therapy adherence.”

To learn more about Inspire, please visit InspireSleep.com or capefearvalley.com/sleep.

Ico insights

INSIGHTS

SPONSORS' CONTENT

In The Current Issue

A new chapter: Book Black Women Inc. deepens impact with new partnerships and new programming

In just four short years, Book Black Women Inc. has flourished exponentially. New partnerships, serious sponsorships, a new location and putting on an all-original play are just some of the accomplishments on the horizon for Ayana Washington’s creati


Elevating the golf experience: The entrepreneurs behind Chip Shot Golf's ambitious drone delivery vision

Bobby Kulp and Forth Heffner, the entrepreneurs behind Chip Shot Golf, are hoping their drone delivery service can become a household name for golfers who want to experience maximum comfort on demand. Photo provided by Kulp.An entrepreneur and tech w


Editor's note: Celebrating Spring in Fayetteville

Photo by Stephanie MeadorAs the trees and bushes bloom and the weather heats up, I’m enjoying spending more and more time outdoors, walking on trails, dining on patios and even driving with the windows down to soak in the fresh air. I’ve always